Interleukin-1 receptor antagonist (IL-1ra) modulates endothelial cell proliferation

FEBS Lett. 2008 Mar 19;582(6):886-90. doi: 10.1016/j.febslet.2008.02.021. Epub 2008 Feb 20.

Abstract

Endothelial cell (EC) lifespan controlled by the IL-1 family of cytokines is an important determinant of susceptibility to artery wall disease. Here we show that EC lacking intracellular interleukin-1 receptor antagonist (IL-1ra) have a reduced lifespan compared to controls. Over expression of IL-1ra enhanced proliferation via cyclin dependent kinase 2 activity and retinoblastoma protein phosphorylation. This was not seen in EC lacking IL-1 receptor 1 (IL-1 signalling ability), nor apparent using other stimuli e.g. TNF alpha. These data suggest that IL-1ra has a specific and receptor-dependent function to control the growth and lifespan of EC.

MeSH terms

  • Animals
  • Apoptosis
  • Cell Proliferation*
  • Cellular Senescence* / genetics
  • Cyclin-Dependent Kinase 2
  • Endothelial Cells / cytology*
  • Endothelial Cells / metabolism
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / genetics
  • Interleukin 1 Receptor Antagonist Protein / metabolism*
  • Interleukin-1beta / metabolism
  • Mice
  • Mice, Mutant Strains
  • Retinoblastoma Protein / metabolism

Substances

  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1beta
  • Retinoblastoma Protein
  • Cyclin-Dependent Kinase 2